000403 派林生物
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产326-2.10%33336200
固定资产993,0525.31%942,994873,673739,736350,240
在建工程619,4356.30%582,700385,735334,37632,732
无形资产212,6980.05%212,593192,516200,05265,460
商誉2,614,6120.00%2,614,6122,614,6122,614,6120
其他非流动资产835,774-1.81%851,167868,452729,696358,583
5,275,8961.37%5,204,3994,935,3494,618,471807,014

流动资产
货币资金988,509-30.84%1,429,3501,000,797885,673102,827
应收账款485,704-16.77%583,579835,877535,379277,491
存货1,104,86521.50%909,375623,689738,968441,761
其他流动资产862,83271.27%503,771586,612309,30750,634
3,441,9110.46%3,426,0753,046,9762,469,327872,713

流动负债
短期借款275,87110.10%250,571275,102113,519332,406
应付票据0--0000
应付帐款158,1362.45%154,347158,370170,76145,487
其他流动负债425,089-17.82%517,276525,837358,009267,621
859,095-6.84%922,195959,309642,289645,514
流动资产净值2,582,8153.15%2,503,8802,087,6671,827,038227,199
资产总额减流动负债7,858,7121.95%7,708,2807,023,0166,445,5091,034,214

非流动负债
长期借款227,75416.15%196,07952,886020,022
应付债券0--0000
其他非流动负债86,407-4.35%90,337109,002117,77947,285
314,1619.69%286,416161,888117,77967,307

总权益
    实收股本732,787-0.03%733,001732,387732,919492,435
    储备项目6,818,7521.84%6,695,6496,135,1375,592,745472,881
股东权益7,551,5391.65%7,428,6496,867,5246,325,664965,316
非控股权益(6,988)2.99%(6,785)(6,397)2,0661,590